Akero Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two
Akero Therapeutics, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Two of $208.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2025-11-07
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $208.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $208.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $208.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $351.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two |
|---|---|
| 2025-09-30 | $208.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $208.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $208.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $351.00K 10-K · filed 2025-02-28 |
| 2024-09-30 | $351.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $351.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $351.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $341.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $341.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $341.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $341.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $331.00K 10-K · filed 2023-03-17 |
| 2022-09-30 | $331.00K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $331.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $331.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $321.00K 10-K · filed 2022-02-25 |
| 2021-09-30 | $321.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $321.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $321.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $312.00K 10-K · filed 2021-03-16 |
| 2020-09-30 | $312.00K 10-Q · filed 2020-11-12 |
| 2020-03-31 | $61.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $80.00K 10-K · filed 2022-02-25 |